Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Expert Opinion on Emerging Drugs|December 3, 2008
Parkinson's disease: emerging pharmacotherapyKarl Strecker, Johannes Schwarz
Neurosurgery|December 6, 2008
Increase of frequency in deep brain stimulation relieves apraxia of eyelid opening in patients with Parkinson's disease: case reportKarl Strecker, Jürgen Meixensberger, Johannes Schwarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2012
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient miceKarl Strecker, Michael Adamaszek, Sven Ohm, et al.
Social Cognitive and Affective Neuroscience|September 8, 2012
An ERP study of vocal emotion processing in asymmetric Parkinson's diseasePatricia Garrido-Vásquez, Marc D Pell, Silke Paulmann, et al.
Plos One|March 26, 2014
Adaptive gene regulation in the Striatum of RGS9-deficient miceKathy Busse, Rainer Strotmann, Karl Strecker, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 31, 2010
Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trialMartin Wolz, Matthias Löhle, Karl Strecker, et al.
Journal of Neurology|July 21, 2010
Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporterKarl Strecker, Florian Wegner, Swen Hesse, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2008
Monoamine transporter availability in Parkinson's disease patients with or without depressionSwen Hesse, Philipp M Meyer, Karl Strecker, et al.
Parkinsonism & Related Disorders|November 19, 2008
Developmental perspectives on human midbrain-derived neural stem cellsJohannes Schwarz
Pageof 13